Page 4 - Imaging Phenomics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Business Wire. The AP news staff was not involved in its creation. iBiopsy®: Median Technologies Inks a Major Research Collaboration Agreement With the University of California San Diego (UC San Diego) February 9, 2021 GMT Regulatory News: Median Technologies (Paris:ALMDT) (ALMDT:PA) announces today the company has signed a research collaboration agreement with the University of California San Diego (UC San Diego) aimed at carrying out a study that will be used for its proprietary imaging platform iBiopsy® validation. The study is related to the iBiopsy® NASH Cli...

(1) The research collaboration agreement covers a joint clinical retrospective study on liver fibrosis severity in Non-Alcoholic Steato-Hepatitis (NASH) patients The collaboration will enable Median to work on a large NASH patient cohort to lead the validation of its iBiopsy's AI technology, applied to liver fibrosis characterization The Liver Center at UC San Diego is a world-renowned university and healthcare center for liver diseases, with a focus on Non-Alcoholic Fatty Liver Disease (NAFLD) NASH Regulatory News: Median Technologies (Paris:ALMDT) (ALMDT:PA) announces today the company has ...

Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares

Regulatory News: Under the liquidity contract entrusted by Median Technologies (Paris:ALMDT) (FR0011049824 ALMDT FP) to Louis Capital Markets|Midcap Partners, the following resources were listed in

Median Technologies Records a 51 % Increase of Its 2020 Annual Revenue (Unaudited Figures) As of December 31, 2020, order backlog of €51.7 million, up 35 compared to December 31, 2019 Cash and cash equivalents of €16.3 million as of December 31, 2020 Regulatory News: Median Technologies (Paris:ALMDT) (ALMDT) today announces strong business activity for the full year 2020 (unaudited figures). In 2020, despite the Covid-19 pandemic and global health crisis, the company continued to grow at a sustained pace while increasing its headcount of 33 globally (141 employees as of December 31, 2020 ...